Skip to main content
Top
Published in: Annals of Surgical Oncology 2/2010

01-02-2010 | Gastrointestinal Oncology

Malignant Ascites Symptom Cluster in Patients Referred for Paracentesis

Authors: Amna Husain, MD, MPH, Andrea Bezjak, MD, MSc, Alexandra Easson, MD, MSc

Published in: Annals of Surgical Oncology | Issue 2/2010

Login to get access

Abstract

Background

Malignant ascites (MA) is a distressing problem usually managed by repeated paracenteses. Paracentesis represents a meaningful time point in identifying patients with a specific presentation.

Objective

The objective of this study is to examine symptom clustering in MA patients at paracentesis.

Methods

Pre- and post-paracentesis, patients completed the Edmonton Symptom Assessment Scale revised to include abdominal distension and mobility (ESAS:AM) and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). This is a secondary analysis of data previously published, which reported on the validity of these surveys in MA. The symptoms were clustered using a hierarchical cluster analysis technique.

Results

In 37 cancer patients with complete data, there were two clusters common at both pre- and post-paracentesis time points: (1) depression–anxiety; (2) fatigue–appetite–wellbeing–mobility. Paracentesis resulted in an improvement in ESAS/AM total score (SDS/AM), abdominal distension, and shortness of breath (P < 0.001, threshold adjusted for multiple comparisons). On the EORTC QLQ-C30, the domains of role functioning and global quality of life (QOL) showed a trend towards improvement, while the domains of cognitive and emotional QOL declined significantly (P < 0.001, threshold adjusted for multiple comparisons), despite improvement in individual symptoms commonly attributed to ascites.

Conclusions

This study is the first to describe symptom clusters in MA. Studies in MA should include measurement of the more global symptoms of fatigue, wellbeing, depression, and anxiety in addition to shortness of breath, abdominal distension, and mobility. Patients presenting with MA require a comprehensive assessment and a management plan that addresses QOL and the emotional domain symptoms shown to cluster in these patients.
Literature
1.
go back to reference Kim HJ, McGuire DB, Tulman L, Barsevick AM. Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs. 2005;28(4):270–82.CrossRefPubMed Kim HJ, McGuire DB, Tulman L, Barsevick AM. Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs. 2005;28(4):270–82.CrossRefPubMed
2.
go back to reference Woods NF, Mitchell ES, Lentz M. Premenstrual symptoms: delineating symptom clusters. J Womens Health Gend Based Med. 1999;8(8):1053–62.PubMed Woods NF, Mitchell ES, Lentz M. Premenstrual symptoms: delineating symptom clusters. J Womens Health Gend Based Med. 1999;8(8):1053–62.PubMed
3.
go back to reference Lacasse C, Beck SL. Clinical assessment of symptom clusters. Semin Oncol Nurs. 2007;23(2):106–12.CrossRefPubMed Lacasse C, Beck SL. Clinical assessment of symptom clusters. Semin Oncol Nurs. 2007;23(2):106–12.CrossRefPubMed
4.
go back to reference Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum. 2001;28(3):465–70.PubMed Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum. 2001;28(3):465–70.PubMed
5.
go back to reference Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN. Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manage. 2006;31(1):85–95.CrossRefPubMed Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN. Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manage. 2006;31(1):85–95.CrossRefPubMed
6.
go back to reference Parsons SL, Lang MW, Steele RJ. Malignant ascites: a 2-year review from a teaching hospital. Eur J Surg Oncol. 1996;22(3):237–9.CrossRefPubMed Parsons SL, Lang MW, Steele RJ. Malignant ascites: a 2-year review from a teaching hospital. Eur J Surg Oncol. 1996;22(3):237–9.CrossRefPubMed
7.
go back to reference Mackey JR, Venner PM. Malignant ascites: demographics, therapeutic efficacy and predictors of survival. Can J Oncol. 1996;6(2):474–80.PubMed Mackey JR, Venner PM. Malignant ascites: demographics, therapeutic efficacy and predictors of survival. Can J Oncol. 1996;6(2):474–80.PubMed
8.
go back to reference Easson AM, Bezjak A, Ross S, Wright JG. The ability of existing questionnaires to measure symptom change after paracentesis for symptomatic ascites. Ann Surg Oncol. 2007;14(8):2348–57.CrossRefPubMed Easson AM, Bezjak A, Ross S, Wright JG. The ability of existing questionnaires to measure symptom change after paracentesis for symptomatic ascites. Ann Surg Oncol. 2007;14(8):2348–57.CrossRefPubMed
9.
go back to reference Geisser M, Perna R, Kirsch N, Bachman J. Classification of chronic pain patients with the brief symptom inventory: patient characteristics of cluster profiles. Rehabil Psychol. 1998;43:313–26.CrossRef Geisser M, Perna R, Kirsch N, Bachman J. Classification of chronic pain patients with the brief symptom inventory: patient characteristics of cluster profiles. Rehabil Psychol. 1998;43:313–26.CrossRef
10.
go back to reference Walsh D, Rybicki L. Symptom clustering in advanced cancer. Support Care Cancer. 2006;14(8):831–6.CrossRefPubMed Walsh D, Rybicki L. Symptom clustering in advanced cancer. Support Care Cancer. 2006;14(8):831–6.CrossRefPubMed
11.
go back to reference Cleeland CS, Mendoza TR, Wang XS et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 20001;89(7):1634–46.CrossRefPubMed Cleeland CS, Mendoza TR, Wang XS et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 20001;89(7):1634–46.CrossRefPubMed
12.
go back to reference Johnson R, Wichern D. Applied multivariate statistical analysis. Prentice-Hall: Upper Saddle River; 1982. Johnson R, Wichern D. Applied multivariate statistical analysis. Prentice-Hall: Upper Saddle River; 1982.
13.
go back to reference Kupier F, Fisher L. Monte Carlo comparison of six clustering procedures. Biometrics. 1975;31:777–83.CrossRef Kupier F, Fisher L. Monte Carlo comparison of six clustering procedures. Biometrics. 1975;31:777–83.CrossRef
14.
go back to reference Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer. 2000;88(9):2164–71.CrossRefPubMed Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer. 2000;88(9):2164–71.CrossRefPubMed
15.
go back to reference Philip J, Smith WB, Craft P, Lickiss N. Concurrent validity of the modified Edmonton Symptom Assessment System with the Rotterdam Symptom Checklist and the Brief Pain Inventory. Support Care Cancer. 1998;6(6):539–41.CrossRefPubMed Philip J, Smith WB, Craft P, Lickiss N. Concurrent validity of the modified Edmonton Symptom Assessment System with the Rotterdam Symptom Checklist and the Brief Pain Inventory. Support Care Cancer. 1998;6(6):539–41.CrossRefPubMed
17.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.CrossRefPubMed Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.CrossRefPubMed
18.
go back to reference Bjordal K, de GA, Fayers PM, et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer. 2000;36(14):1796–807.CrossRefPubMed Bjordal K, de GA, Fayers PM, et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer. 2000;36(14):1796–807.CrossRefPubMed
19.
go back to reference Osoba D, Zee B, Pater J, Warr D, Kaizer L, Latreille J. Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual Life Res. 1994;3(5):353–64.CrossRefPubMed Osoba D, Zee B, Pater J, Warr D, Kaizer L, Latreille J. Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual Life Res. 1994;3(5):353–64.CrossRefPubMed
20.
go back to reference Teunissen SC, de GA, Voest EE, de Haes JC. Are anxiety and depressed mood related to physical symptom burden? A study in hospitalized advanced cancer patients. Palliat Med. 2007;21(4):341–6.CrossRefPubMed Teunissen SC, de GA, Voest EE, de Haes JC. Are anxiety and depressed mood related to physical symptom burden? A study in hospitalized advanced cancer patients. Palliat Med. 2007;21(4):341–6.CrossRefPubMed
21.
go back to reference Vignaroli E, Pace EA, Willey J, Palmer JL, Zhang T, Bruera E. The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med. 2006;9(2):296–303.CrossRefPubMed Vignaroli E, Pace EA, Willey J, Palmer JL, Zhang T, Bruera E. The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med. 2006;9(2):296–303.CrossRefPubMed
22.
go back to reference Miaskowski C, Cooper BA, Paul SM, et al. Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum. 2006;33(5):E79–89.CrossRefPubMed Miaskowski C, Cooper BA, Paul SM, et al. Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum. 2006;33(5):E79–89.CrossRefPubMed
23.
go back to reference Dodd MJ, Miaskowski C, Lee KA. Occurrence of symptom clusters. J Natl Cancer Inst Monogr. 2004;32:76–8. Dodd MJ, Miaskowski C, Lee KA. Occurrence of symptom clusters. J Natl Cancer Inst Monogr. 2004;32:76–8.
24.
go back to reference Gift AG, Jablonski A, Stommel M, Given CW. Symptom clusters in elderly patients with lung cancer. Oncol Nurs Forum. 2004;31(2):202–12.CrossRefPubMed Gift AG, Jablonski A, Stommel M, Given CW. Symptom clusters in elderly patients with lung cancer. Oncol Nurs Forum. 2004;31(2):202–12.CrossRefPubMed
25.
go back to reference Kurtz ME, Kurtz JC, Given CW, Given B. Loss of physical functioning among patients with cancer: a longitudinal view. Cancer Pract. 1993;1(4):275–81.PubMed Kurtz ME, Kurtz JC, Given CW, Given B. Loss of physical functioning among patients with cancer: a longitudinal view. Cancer Pract. 1993;1(4):275–81.PubMed
26.
27.
go back to reference Becker G, Galandi D, Blum HE. Malignant ascites: systematic review and guideline for treatment. Eur J Cancer. 2006;42(5):589–97.CrossRefPubMed Becker G, Galandi D, Blum HE. Malignant ascites: systematic review and guideline for treatment. Eur J Cancer. 2006;42(5):589–97.CrossRefPubMed
Metadata
Title
Malignant Ascites Symptom Cluster in Patients Referred for Paracentesis
Authors
Amna Husain, MD, MPH
Andrea Bezjak, MD, MSc
Alexandra Easson, MD, MSc
Publication date
01-02-2010
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 2/2010
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-009-0774-0

Other articles of this Issue 2/2010

Annals of Surgical Oncology 2/2010 Go to the issue